Hyderabad Telangana, India

Sreenivasulu Kurella

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sreenivasulu Kurella. Retrieved from https://idiyas.com/inventor/sreenivasulu-kurella

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sreenivasulu Kurella: Innovator in Pharmaceutical Chemistry

Introduction

Sreenivasulu Kurella is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of Ticagrelor, a medication used to reduce the risk of heart attacks and strokes.

Latest Patents

Sreenivasulu Kurella holds a patent for the "Preparation of Ticagrelor." This patent includes processes for preparing Ticagrelor and its intermediates that are useful in the manufacturing processes. Additionally, it covers the salts of Ticagrelor, their processes, and solid dispersion of Ticagrelor in an amorphous form. He has 1 patent to his name.

Career Highlights

Sreenivasulu Kurella is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its innovative drug development. His work focuses on enhancing the efficiency and effectiveness of pharmaceutical formulations.

Collaborations

Some of his notable coworkers include Vilas Hareshwar Dahanukar and Goverdhan Gilla, who contribute to the collaborative efforts in research and development at Dr. Reddy's Laboratories.

Conclusion

Sreenivasulu Kurella's work in the preparation of Ticagrelor showcases his expertise and dedication to advancing pharmaceutical science. His contributions are vital in improving healthcare outcomes through innovative drug formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…